In Vitro Method Services
7 services found
Manufactured by:Cell Culture Company, LLC based inMinneapolis, MINNESOTA (USA)
Are you looking for recombinant antibody production services for antibody characterization, screening, or preclinical studies? Cell Culture Company offers a wide selection of offerings to meet your needs. With our 40+ years of experience ranging from purification and downstream processing to recombinant antibody production, you can expect excellent results and relatively lower production costs. ...
Manufactured by:InnoSer Belgie NV based inDiepenbeek, BELGIUM
In vitro and in vivo methods to provide a study setup that thoroughly determines safety and efficacy. ...
by:iFyber, LLC based inIthaca, NEW YORK (USA)
iFyber provides a suite of biofilm tests to verify the efficacy of antimicrobial medical devices and drugs. Biofilms are complex communities of microbes protected within a matrix of sugars, proteins, and extracellular DNA. These characteristics, in addition to their tolerance to antibiotics, make biofilms significantly more difficult to prevent and remove. Research has shown that between 60 to ...
Manufactured by:InnoSer Belgie NV based inDiepenbeek, BELGIUM
We move your identified hits forward into in vivo testing and lead optimization. As a critical phase in your drug development journey, the hit to lead phase will determine which of your promising compounds will be characterized against your targets. With a lean ethos, InnoSer is dedicated to combining our expertise with your drug development goals in the most resource efficient way. During this ...
Manufactured by:CD Bioparticles based inShirley, NEW YORK (USA)
CD Bioparticles offers one-stop drug-carrier complex analysis package service including drug in vitro testing using advanced techniques. Our experienced scientists have created a comprehensive platform to measure the drug in vitro testing from different ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
The inauguration of monoclonal antibodies (mAbs), derived from mice, were immunogenic in humans. These molecules were first synthesized in 1975 by Georges Köhler and César Milstein through the use of hybridoma technology. Later, in 1984, another milestone was achieved with the production of chimeric human antibodies via recombinant DNA technology. Hybridoma technology facilitates the creation of ...
by:TÜV SÜD America Inc. based inWakefield, MASSACHUSETTS (USA)
In the medical field, practitioners utilize a range of devices to address patient health, from diagnosis to surgery. When the patient comes into contact with a medical device or material, it should fulfill its intended function without harming the patient. Therefore, all medical devices need to undergo a thorough biological risk assessment to protect the patient from any toxic, physiological, ...